3,4-Dihydroxymethamphetamine
Chemical compound related to methamphetamine
3,4-Dihydroxymethamphetamine (also known as HHMA) is a catecholamine and a metabolite of the psychoactive drug methamphetamine. It is structurally related to dopamine and norepinephrine, which are important neurotransmitters in the central nervous system.
Chemical Structure and Properties

3,4-Dihydroxymethamphetamine is characterized by the presence of two hydroxyl groups attached to the benzene ring, which is a common feature of catecholamines. The chemical formula is C10H15NO2, and it has a molecular weight of 181.23 g/mol. The presence of the hydroxyl groups makes it more polar than its parent compound, methamphetamine, affecting its solubility and interaction with biological systems.
Biological Activity
3,4-Dihydroxymethamphetamine is primarily formed in the body as a result of the metabolism of methamphetamine. It is produced through the action of the enzyme cytochrome P450 on methamphetamine, followed by further oxidation. This compound is thought to contribute to some of the pharmacological effects of methamphetamine, although it is less potent than methamphetamine itself.
Metabolism
In the human body, methamphetamine is metabolized by the liver. The primary metabolic pathway involves the conversion of methamphetamine to amphetamine, which is then further metabolized to 3,4-Dihydroxymethamphetamine. This process involves several enzymatic steps, including the action of monoamine oxidase and catechol-O-methyltransferase.
Pharmacological Effects
While 3,4-Dihydroxymethamphetamine is not as potent as methamphetamine, it may still have some effects on the central nervous system. It is believed to interact with dopamine receptors and norepinephrine receptors, potentially contributing to the stimulant effects of methamphetamine. However, its exact role in the overall pharmacological profile of methamphetamine is not fully understood.
Toxicity and Safety
The toxicity of 3,4-Dihydroxymethamphetamine is not well-documented, but it is generally considered to be less toxic than methamphetamine. However, as a metabolite of methamphetamine, it may still contribute to the overall toxicity of methamphetamine use, particularly in cases of overdose or chronic use.
Research and Implications
Research into 3,4-Dihydroxymethamphetamine is ongoing, with studies focusing on its role in the metabolism of methamphetamine and its potential effects on the brain. Understanding the metabolism and effects of this compound could provide insights into the mechanisms of action of methamphetamine and help in the development of treatments for methamphetamine addiction.
Related Pages
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian